Iopamidol
Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media
Sold as ISOVUE-M · GASTROMIRO · ISOVUE MULTIPACK-370 · ISOVUE MULTIPACK-300
- Drug class
- Watersoluble, Nephrotropic, Low Osmolar X-Ray Contrast Media
- Availability
- Prescription only
- Routes
- Intravascular, Intrathecal
- Markets covered
- 3
- Products on record
- 13
- FDA reports (12 mo)
- 236
Overview
Plain-language summary, compiled from the cited regulatory records
Iopamidol is a watersoluble, low osmolar X-ray contrast medium [1]. It is used in neuroradiology for intrathecal administration in adults, including myelography (lumbar, thoracic, cervical, and total columnar) [1]. It is also approved for contrast enhancement in computed tomographic (CT) cisternography and ventriculography in adults [1]. For children over two years of age, Iopamidol Injection, 41% is specifically indicated for thoraco-lumbar myelography [1].
This medication is available under various brand names, including ISOVUE-M [1]. In the past 12 months, there have been 236 adverse event reports associated with Iopamidol [2]. Common adverse events reported include nausea, urticaria, anaphylactic reaction, dizziness, and dyspnoea [1].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 6 | February 20, 2026 |
| CA Canada | Health Canada | 5 | March 22, 2025 |
| US United States | FDA | 2 | February 10, 2026 |
GBUnited Kingdom· MHRA
6 products
Uses
This medicinal product is for diagnostic use only. X-ray contrast media for peripheral arteriography and venography, angiocardiography, digital subtraction angiography, left ventriculography and coronary arteriography, computer tomography enhancement and urography
How to take
CACanada· Health Canada
5 products
Uses
2 Geriatrics Geriatrics: Evidence from clinical studies and experience suggests that use in the geriatric population may be associated with differences in safety or effectiveness (see 7 WARNINGS AND PRECAUTIONS). Product Monograph ISOVUE® (iopamidol) Page 6 of 45
How to take
USUnited States· FDA
2 products
Uses
3 )].
ISOVUE-M is a radiographic contrast agent indicated for:
Lumbar and thoracic myelography and computed tomography (CT) myelography in adults and pediatric patients aged 2 years and older Cervical and total columnar myelography in adults CT cisternography in adults ( 1 ) Specific concentrations of ISOVUE-M are recommended for each type of imaging procedure.
3 )
How to take
Drug interactions
Known interactions involving Iopamidol. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 310. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL529100003 · revised February 20, 2026
- [2]Health Canada (DPD) · 02229013 · revised March 22, 2025
- [3]FDA DailyMed · 11e893d2-0183-45… · revised February 10, 2026 [PDF]
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.